ANIXA BIOSCIENCES, INC. Noncontrolling Interest, Increase from Subsidiary Equity Issuance
ANIXA BIOSCIENCES, INC. (ANIX) reported Noncontrolling Interest, Increase from Subsidiary Equity Issuance of $64.66 thousand for the 12-month period ending 2018-10-31, per its 10-K filed 2020-01-09.
Discontinued › Shareholders' Equity
us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance · last filed 2020-01-09
- ANIXA BIOSCIENCES, INC. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2018-10-31 was $0.00.
- ANIXA BIOSCIENCES, INC. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2018-07-31 was $0.00.
- ANIXA BIOSCIENCES, INC. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2018-04-30 was $0.00.
- ANIXA BIOSCIENCES, INC. noncontrolling interest, increase from subsidiary equity issuance for the quarter ending 2018-01-31 was $64.66K.
- ANIXA BIOSCIENCES, INC. noncontrolling interest, increase from subsidiary equity issuance for fiscal 2018 was $64.66K.
| Period end | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 3 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 6 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 9 month | Noncontrolling Interest, Increase from Subsidiary Equity Issuance 12 month |
|---|---|---|---|---|
| 2018-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | $0.00 derived: sum of 2 quarters · filed 2020-01-09 | $0.00 derived: sum of 3 quarters · filed 2020-01-09 | $64.66K 10-K · filed 2020-01-09 |
| 2018-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-09-06 | $0.00 derived: sum of 2 quarters · filed 2019-09-06 | $64.66K 10-Q · filed 2019-09-06 | |
| 2018-04-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-06-12 | $64.66K 10-Q · filed 2019-06-12 | ||
| 2018-01-31 | $64.66K 10-Q · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |